Key Takeaways Norwegian Cruise Line's Q3 EPS of $1.20 topped estimates, while revenues of $2.94B missed forecasts.Occupancy hit 106.4%, fueled by robust Caribbean demand and strong booking momentum into 2026.For 2025, NCLH expects EPS of $2.10 and occupancy of 103.5%, both higher than previous projections.Norwegian Cruise Line Holdings Ltd. (NCLH) reported third-quarter 2025 results, with earnings beating the Zacks Consensus Estimate, but revenues missing the same. Following the results, the company’s share ...

You can find original article here Nrn. Subscribe to our free daily Nrn newsletters. Wingstop Inc. reported a 5.6% drop in U.S. same-store sales for the third quarter of 2025 as the company laps a record-breaking period of robust growth from the past two years.  The same-store sales declines were steeper than expected, executives said during the third-quarter earnings call Tuesday, though CEO Michael Skipworth said he expects the downturn to be temporary. “We shared earlier this year that certain r ...

Nov 4, 2025 12:06 PM Eastern Standard Time Law Offices of Frank R. Cruz Encourages James Hardie Industries plc (JHX) Shareholders To Inquire About Securities Fraud Class Action Share LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased James Hardie Industries plc ("James Hardie†or the "Company†) (NYSE: JHX) common stock (previously American Depositary Shares until the Company's conversion to common stock ...

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) ("uniQure†). On November 3, 2025, uniQure issued a press release revealing that the FDA notified the company that data for its AMT-130, an investigational gene therapy for Huntington's disease, did not provide sufficient evidence to support uniQure's Biologics Licen ...

Core Viewpoint - James Hardie Industries plc is facing a challenging period due to a class action securities lawsuit, yet Citigroup has upgraded its stock from Neutral to Buy, indicating confidence in the company's future performance [2][3][5] Company Overview - James Hardie is a global leader in fiber cement products, known for innovative building materials used in residential and commercial construction [1] - The company competes with other building material firms such as Boral and CSR Limited [1] Stock Performance - As of the latest update, James Hardie's stock is trading at $20.45, reflecting a 2.29% decrease with a drop of $0.48 [4][5] - The stock has experienced significant volatility over the past year, with a high of $37.65 and a low of $17.85 [4][5] - The company's market capitalization is approximately $11.83 billion, with a trading volume of 3,104,227 shares [4] Legal Issues - A class action lawsuit initiated by Levi & Korsinsky, LLP, alleges that James Hardie made false statements or concealed adverse facts regarding its North America segment, particularly about consumer demand and growth [2][3] - Investors affected by the lawsuit are encouraged to contact Levi & Korsinsky before December 23, 2025, to explore their rights and recovery options [3]

TORONTO, ON / ACCESS Newswire / November 4, 2025 / AmeriTrust Financial Technologies Inc. (TSXV:AMT)(OTCQB:AMTFF)(Frankfurt:1ZVA) ("AmeriTrust" or the "Company"), a fintech platform targeting automotive finance and specializing in used vehicle lease originations for the automotive industry, is pleased to announce that on October 30th, 2025, it entered into an agreement to be the National Lease Partner for myAutoloan.com. myAutoloan.com is a privately held, direct to consumer online automotive finance market ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In WPP To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $10,000 in WPP between February 27, 2025 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) ...

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another. Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a ...

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fly-E Group, Inc. (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Fly-E securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...